national rosacea society nrs nonprofit organization dedicated improving lives estimated million americans suffer rosacea chronic facial skin disorder mission raise awareness provide health information support medical research may lead improvement management prevention potential cure although rosacea first described guy de chauliac century included chaucers canterbury national rosacea society founded rosacea still considered rare disease first approved treatment topical metronidazole received orphan drug designation us food drug administration belief fewer americans suffered soon became evident rosacea affected lives millions previously failed realize medical condition could treated study estimated global incidence rosacea equivalent around national rosacea society designates april rosacea awareness conducts national communications public relations social media activities throughout year society also produces patient education national rosacea society launched patientfunded research grants program support scientific research potential causes key aspects rosacea may lead improvements management prevention potential cure etiology rosacea unknown high priority awarding grants given studies relating areas pathogenesis progression mechanism action cell biology potential genetic factors rosacea research areas epidemiology predisposition quality life relationships environmental lifestyle factors may also since inception million awarded support provide basis meaningful scientific investigation nrs organized consensus committee review panel medical experts establish standard definition classification system rosacea published well standard grading system published classification system instrumental establishing clinical rosacea papulopustular rosacea phymatous rosacea ocular used describe nrs consensus committee review panel medical experts published standard management options nrs consensus committee review panel medical experts published updated classification pathophysiology reflecting increased understanding disease progression gained years since original classification published updated classification shifted focus away subtypes phenotype approach article accompanied editorial rosacea comorbidities areas future nrs consensus committee review panel medical experts published updates standard management options intended provide comprehensive summary treatment options respective phenotypes identified updated standard classification rosacea recommending physicians tailor therapy patients individual httpsenwikipediaorgwikinationalrosaceasociety